The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study Journal Article


Authors: van Hees, F.; Zauber, A. G.; Klabunde, C. N.; Goede, S. L.; Lansdorp-Vogelaar, I.; Van Ballegooijen, M.
Article Title: The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
Abstract: Importance: Many Medicare beneficiaries undergo more intensive colonoscopy screening than recommended. Whether this is favorable for beneficiaries and efficient from a societal perspective is uncertain. Objective: To determine whether more intensive colonoscopy screening than recommended is favorable for Medicare beneficiaries (ie, whether it results in a net health benefit) and whether it is efficient from a societal perspective (ie, whether the net health benefit justifies the additional resources required). Design, Setting, and Participants: Microsimulation modeling study of 65-year-old Medicare beneficiaries at average risk for colorectal cancer (CRC) and with an average life expectancy who underwent a screening colonoscopy at 55 years with negative results. Interventions: Colonoscopy screening as recommended by guidelines (ie, at 65 and 75 years) vs scenarios with a shorter screening interval (5 or 3 instead of 10 years) or in which screening was continued to 85 or 95 years. Main Outcomes and Measures: Quality-adjusted life-years (QALYs) gained (measure of net health benefit); additional colonoscopies required per additional QALY gained and additional costs per additional QALY gained (measures of efficiency). Results: Screening previously screened Medicare beneficiaries more intensively than recommended resulted in only small increases in CRC deaths prevented and life-years gained. In comparison, the increases in colonoscopies performed and colonoscopy-related complications experienced were large. As a result, all scenarios of more intensive screening than recommended resulted in a loss of QALYs, rather than a gain (ie, a net harm). The only exception was shortening the screening interval from 10 to 5 years, which resulted in 0.7 QALYs gained per 1000 beneficiaries. However, this scenario was inefficient because it required no less than 909 additional colonoscopies and an additional $711 000 per additional QALY gained. Results in previously unscreened beneficiaries were slightly less unfavorable, but conclusions were identical. Conclusions and Relevance: Screening Medicare beneficiaries more intensively than recommended is not only inefficient from a societal perspective; often it is also unfavorable for those being screened. This study provides evidence and a clear rationale for clinicians and policy makers to actively discourage this practice.
Keywords: adult; controlled study; aged; major clinical study; cancer risk; colorectal cancer; cancer screening; practice guideline; cancer mortality; groups by age; simulation; cost effectiveness analysis; health insurance; medicare; disease severity; cardiovascular disease; colonoscopy; colorectal adenoma; cancer size; gastrointestinal disease; life expectancy; polypectomy; quality adjusted life year; predictive value; microsimulation model; colon biopsy; society; human; article
Journal Title: JAMA Internal Medicine
Volume: 174
Issue: 10
ISSN: 2168-6106
Publisher: American Medical Association  
Date Published: 2014-10-01
Start Page: 1568
End Page: 1576
Language: English
DOI: 10.1001/jamainternmed.2014.3889
PROVIDER: scopus
PUBMED: 25133641
PMCID: PMC4416697
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ann G Zauber
    314 Zauber